News

The Phase I/II study evaluated multiple doses of tgAAC94 administered directly to affected joints with or without concurrent systemic tumor necrosis factor (TNF) antagonist therapies. The study achieved

Under the contract, Angel will manufacture and supply GMP materials for use in a bacteriophage-based MRSA prophylactic treatment as part of a Phase I/II clinical trial scheduled to

Pfizer is not alone – other drugmakers across Europe are trying to evade the traditional wholesale route to pharmacies and are appointing one or more companies as logistic

According to Hamish Meldrum, chairman of the British Medical Association (BMA) council, new research shows that patients with formal educational background are more likely to prefer treatment in

With this agreement, Sono Bello Contouring Centers will use the LipoLite and VelaShape technology in each of the 30 clinic locations to provide the company’s body contouring related

These funds will expedite implementation of the strategy outlined in the Action Plan for Import Safety and the complementary Food Protection Plan, both released in November 2007. The

Mr Hetherington has a broad range of experience in senior financial roles having most recently held positions as the CFO of Bacardi (2007) and Allied Domecq (1999-2005). As

Michael Pearson, chairman and CEO of Valeant, said: “One of our strategic initiatives for 2008 is to divest certain regions and simplify our operations. The sale of our

Barr filed its abbreviated new drug application (ANDA) containing a paragraph IV certification for a generic Prevacid SoluTab product with the FDA in November 2007. Following receipt of